Company Overview of Multimeric Biotherapeutics, Inc.
Multimeric Biotherapeutics, Inc., a biotechnology company, engages in the development of proteins for creating vaccines and tumor immunotherapies. It focuses on applying its CD40L and other TNF SuperFamily ligands for the creation of vaccines to treat HIV, chronic Hepatitis B virus infection, malaria, influenza, anthrax, Ebola, smallpox, plague, and other microbes; and for inducing the immune destruction of tumors while sparing normal tissues. The company was incorporated in 2008 and is based in La Jolla, California. It has laboratories in Carlsbad, California.
5580 La Jolla Boulevard
La Jolla, CA 92037
Founded in 2008
Key Executives for Multimeric Biotherapeutics, Inc.
Multimeric Biotherapeutics, Inc. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Multimeric Biotherapeutics, Inc., please visit www.multimericbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.